Esketamine Nasal Product: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
7
Countries
Phase breakdown
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Depression | 2 |
| Major Depressive Disorder | 2 |
| Bipolar Depression | 1 |
| Bipolar disorder | 1 |
| Schizophrenia | 1 |
| Schizophrenia and Related Disorders | 1 |
| Treatment Resistant Depression | 1 |
Recruiting trials involving Esketamine Nasal Product
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
- The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Common questions
How many recruiting trials involve Esketamine Nasal Product?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.